A method for combating clostridiosis in broilers and piglets
Rok vydání: | 2021 |
---|---|
Předmět: |
Drug
Veterinary medicine biology business.industry media_common.quotation_subject Broiler Aerospace Engineering Clostridium perfringens medicine.disease_cause biology.organism_classification Systemic circulation Clostridiosis Clostridia chemistry.chemical_compound chemistry medicine medicine.symptom business Weight gain Nosiheptide media_common |
Zdroj: | Agrarian science. :66-70 |
ISSN: | 2686-701X 0869-8155 |
DOI: | 10.32634/0869-8155-2021-347-4-66-70 |
Popis: | Relevance. The problem of clostridia in our country is relevant due to the significant damage to the economy of any enterprise. The fight against clostridiosis is carried out in various directions, including the use of antibacterial drugs. When choosing drugs for antibacterial sanitation, it is advisable to use topical agents (not penetrating into the bloodstream) that are not susceptible to the development of resistance. Methods. The studies were carried out randomly on broiler chickens and rearing piglets diagnosed with clostridiosis. In the experimental groups, the antibacterial drug Nozifor (1% nosiheptide) was used for treatment. Therapeutic efficacy was established on the basis of the clinical status of animals and poultry, data from bacteriological studies, dynamics of recovery and weight gain. Results . The Nozifor preparation, when applied at a dose of 500 g per ton of feed for growing pigs and broilers for 14 days, ensures the eradication of Clostridium perfringens from the intestines and prevents the development of Clostridiosis. Its therapeutic efficacy for clostridiosis at the indicated dose is 100%. The positive effect of the use of the drug Nozifor on the indices of the absolute and average daily gain in live body weight has been established. Nosifor, when taken orally with food, is not absorbed into the systemic circulation, does not accumulate in tissues and organs. |
Databáze: | OpenAIRE |
Externí odkaz: |